永利yl23411|主站首页

Lukang Pharmaceutical

Striving to develop for 50 years
Caring for human health
News Center
Date: 2022.01.26
LUKANG PHARMA WON TWO AWARDS

    Recently, an authoritative and representative China's pharmaceutical industry annual award "Xin Rui" was announced. Shandong Lukang Pharmaceutical Co.,ltd won the “Jin Xi” Award of representing actively taking social responsibility and it’s product--Cefuroxime Axetil dry suspensions, won the “Pu Yu” Award of representing excellent quality. 

dc21cb5620f92d3617f521fa0bf421d.jpgd3f5500bd1d5799589c980fe0999a28.jpg

    Cefuroxime Axetil dry suspensions is the second-generation cephalosporin. It is the first choice for the treatment of children respiratory, skin and soft tissue infection. It has higher safety, less toxicity and adverse reactions.